OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Linda Van Eldik

2 Projects | 1 Researchers | $1,643,524 Invested

2018

University of Kentucky (P)

Linda Van Eldik, PhD

Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease

  • Funding Amount: $1,434,160
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Closed

2014

University of Kentucky (P)

Linda Van Eldik, PhD

Bridge Funding for Reissue of IND for Phase 1b/2a

  • Funding Amount: $209,364
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Closed